Search

everythinglearnresearchcommunity

for

Search:↓

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Finasteride safely lowers DHT levels without affecting testosterone.

Four-amino acid part makes enzyme sensitive to finasteride.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Birth control pills can help reduce mild to moderate acne in women.

New treatments for PCOS focus on managing symptoms and improving fertility.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.